NCT Number: NCT00156169
The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid on Lipid Profile in Fibrate Treated Patients.
The effect of fibrates on high density lipoprotein (HDL)-cholesterol levels is suggested to be mediated by its binding to peroxisome proliferator-activated receptor-g (PPARg). Upon ligand binding, PPARg heterodimerizes with the 9-cis retinoic acid receptor (RXR), and the heterodimer regulates gene expression. We assessed the hypothesis that a dual treatment with fibrate plus 9-cis b-carotene-rich powder of the alga Dunaliella bardawil, as a source of 9-cis retinoic acid, would improve the drug's effect on HDL-cholesterol levels.
patients with plasma HDL-cholesterol levels below 40 mg/dl and triglyceride (TG) levels above 200 mg/dl after fibrate treatment (for at least 6 weeks). are given four capsules of Dunaliella, providing 60 mg b-carotene/day. The all-trans to 9-cis b-carotene ratio in the capsules is about 1:1.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–70 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- age 18-70 years
- Fibrate treatment (for at least 6 weeks)
- HDL-Cholesterol lower than 40mg/dl.
- Triglyceride over 150mg/dl.
Exclusion criteria
- High CPK.
- Elevated liver functions.
- Active CHD.
- Smokers.
- Diabetes patients treated with Insulin or Avandia. HbA1C great than 8.5.
Treatment and study plan
Sponsors and collaborators
Lead sponsor
Sheba Medical Center
Other Gov
Registry information
Official study title
The Effect of the Alga Dunaliella Bardawil as a Source of 9-cis Retinoic Acid
Important dates
- Study start
- 2001
- Study completion
- 2006
- First posted
- Sep 12, 2005
- Registry last updated
- Aug 12, 2009
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Association Between HDL Functions and Atherosclerotic Burden in Healthy Individuals
NCT02106013
Low HDL Cholesterol
Campinas, São Paulo, Brazil
View Trial Details